NeuroOne Medical Technologies Corporation — Revenue by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/4f86b4ec-1123-4778-8a36-7d555bef1f18/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $9.1M | 2024-10-01 – 2025-09-30 | evidence 0001213900-25-122390 |
| FY 2024 | $3.5M | 2023-10-01 – 2024-09-30 | evidence 0001213900-24-109524 |
| FY 2023 | $2.0M | 2022-10-01 – 2023-09-30 | evidence 0001213900-23-096120 |
| FY 2022 | $171.2k | 2021-10-01 – 2022-09-30 | evidence 0001213900-22-081897 |
| FY 2021 | $178.1k | 2020-10-01 – 2021-09-30 | evidence 0001213900-21-065463 |
| FY 2016 | $0 | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-020684 |
| FY 2015 | $0 | 2015-01-01 – 2015-12-31 | evidence 0001144204-17-020684 |
| FY 2014 | $773 | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-023047 |
| FY 2013 | $9.3k | 2009-08-20 – 2014-03-31 | evidence 0001144204-14-032425 |
| FY 2012 | $8.9k | 2009-08-20 – 2013-03-31 | evidence 0001014897-13-000168 |
| FY 2011 | $7.1k | 2009-08-20 – 2012-03-31 | evidence 0001014897-12-000112 |
| FY 2010 | $1.2k | 2010-01-01 – 2010-12-31 | evidence 0001014897-12-000062 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
NeuroOne Medical Technologies Corporation — all facts · Net Income · Operating Income